Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningHematologic NeoplasmsTransplantation, AutologousStem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ChimeraGranulocyte Colony-Stimulating FactorGraft SurvivalBusulfanBone Marrow TransplantationTissue DonorsAntigens, CD34VidarabineTreatment OutcomeLeukapheresisRecurrenceMyeloablative AgonistsGraft vs Leukemia EffectImmunosuppressive AgentsStem CellsMelphalanCombined Modality TherapyHistocompatibility TestingMultiple MyelomaHematopoietic Stem CellsRemission InductionHistocompatibilityRetrospective StudiesCyclophosphamideSurvival AnalysisCord Blood Stem Cell TransplantationLeukemiaWhole-Body IrradiationBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalLeukemia, Myeloid, AcuteTephrosiaLymphoma, Non-HodgkinSurvival RateHematoma, SubduralGraft vs Tumor EffectEtoposideCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte TransfusionMyelodysplastic SyndromesChronic DiseaseAntineoplastic Agents, AlkylatingHLA AntigensLymphocyte DepletionTime FactorsTransplantation, IsogeneicInfectionLiver TransplantationT-LymphocytesThiotepaCytarabineAnemia, AplasticHodgkin DiseaseSiblingsPOEMS SyndromeHematopoiesisNeoplasm, ResidualTransplantation ImmunologyVincristineFollow-Up StudiesCyclosporineHematologic DiseasesMesenchymal Stem Cell TransplantationAntilymphocyte SerumAmyloidosisImmunosuppressionCarmustineFatal OutcomeLymphomaBlood CellsCell TransplantationAcute DiseaseOpportunistic InfectionsKidney TransplantationIfosfamidePrognosisChimerismEmbryonic Stem CellsHepatic Veno-Occlusive DiseaseMinor Histocompatibility AntigensAntineoplastic AgentsBone MarrowPlatelet CountProspective StudiesNeoplasmsImmunophenotypingVirus ActivationBlood DonorsFeasibility Studies